StonvexLoading…
StonvexStonvexStonvexCore line items from XOMA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.35M | $6.65M | $2.65M | $4.15M |
Operating Income | $11.38M | $-39.98M | $-41.85M | $-17.41M |
Net Income | $31.71M | $-13.82M | $-40.83M | $-17.10M |
EPS (Diluted) | $1.46 | $-1.65 | $-4.04 | $-1.98 |
Total Assets | $272.70M | $221.28M | $234.30M | $140.38M |
Total Liabilities | $168.74M | $139.36M | $145.58M | $16.37M |
Cash & Equivalents | $82.91M | $101.65M | $153.29M | $57.83M |
Free Cash Flow OCF − CapEx | Not available | $-13.77M | $-18.18M | $-28.13M |
Shares Outstanding | 11.86M | 11.95M | 11.50M | 11.45M |